A groundbreaking study shows findings that show a treatment can shrink tumors and improve survival outcomes for patients with ...

Ancient stone tools that were discovered in the Tunel Wielki cave in Poland around 50 years ago have been re-examined and dated. Instead of belonging to Neanderthals living in the region these tools ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

Neoantigen-targeting PCVs are highly immunogenic in high-risk clear cell RCC and can target key driver mutations and induce antitumor immunity.

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...

All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

Deputy Steve Lyles has had a rare form of kidney cancer for the past five years. To help Lyles in his fight, the Waukesha ...

FRIDAY, Feb. 14, 2025 (HealthDay News) – Kidney transplants can be lifesaving, but a new study suggests that some recipients ...

In the initial publication in 2021, the KETYNOTE-564 trial demonstrated that adjuvant pembrolizumab was associated with ...